Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

246.71 USD -0.99 (-0.40%)
Streaming Delayed Price Updated: 4:07 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
BioGX Announces FDA Emergency Use Authorization Submission Of Extraction-Free Direct RT-PCR Test for COVID-19
Tags Pharmaceuticals & Biotech
From Get News
BD marks 25 years with Mercy Ships: Donates $1M to support launch of world's largest NGO hospital ship
Global Mercy will deliver free, world-class surgical care to patients in African nations who lack healthcare access 
From PR Newswire
BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System
BD FACSDuet™ Sample Preparation System, now available in the U.S., as the first fully automated sample-to-answer solution when integrated with the BD FACSLyric™ Flow Cytometer 
From PR Newswire
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2020 earnings conference call on Thursday, November... 
From PR Newswire
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October 
From PR Newswire
BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug... 
From PR Newswire
BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Three Recalls Designated as Class I by FDA; One Designated as Class II 
From PR Newswire
New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims
Results show clinical study design may influence performance estimates and published sensitivity claims of SARS-CoV-2 antigen tests 
From PR Newswire
BD to Present at Investor Healthcare Conferences
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming virtual investor healthcare conferences: 
From PR Newswire
ReverseVision Taps Credit Union Veteran Justin Burns as VP Operations, Invests in Platform Enhancements with Hire of Two Senior Software Engineers
Tags California Business San Diego Business Management and Career Moves
From Send2Press Newswire
BD Provides Update on Previously Disclosed Recall of BD Alaris System Hardware
Majority of June 30 Recall Designated as Class I Recall by FDA 
From PR Newswire
Kristen Stewart to Join BD as Senior Vice President of Strategy and Investor Relations
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Kristen Stewart to the newly created position of senior vice president of... 
From PR Newswire
BD to Present at UBS Genomics 2.0 and MedTech Innovations Virtual Summit
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the UBS Genomics 2.0 and MedTech Innovations Virtual Summit on... 
From PR Newswire
BD and BD Foundation commit $7.8 million to helping community health centers expand innovative care to patients
BD (NYSE: BDX), a leading global medical technology company, together with the BD Foundation, its charitable affiliate, today committed $7.8 million in monetary grants and product donations over the... 
From PR Newswire
BD Announces Results For 2020 Third Fiscal Quarter; Provides Fiscal 2020 Guidance
- As reported, revenues of $3.855 billion decreased 11.4 percent 
From PR Newswire
STERIS Announces Financial Results for Fiscal 2021 First Quarter
From GlobeNewswire News Releases
BD releases FY 2019 Sustainability Report
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and... 
From PR Newswire
BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnosic Tests
Capital investments will enable U.S. manufacturing of 8 million BD Veritor™ brand SARS-CoV-2 tests per month 
From PR Newswire
BD Board Declares Dividends
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on September 30, 2020 to holders of record on September 9,... 
From PR Newswire
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD Onclarity™ HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45 
From PR Newswire
BD Receives Additional Orders For 177 Million Injection Devices For U.S., Canada COVID-19 Vaccine Preparations
U.S. Orders 140 Million Additional Devices; Canada Orders 37 Million Additional Devices 
From PR Newswire
BD Supports U.S. Government Efforts to Increase COVID-19 Testing Capacity with Point-of-Care Tests
Government committed to use of BD Veritor™ Plus System and 15-minute SARS-CoV-2 test kits 
From PR Newswire
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
Company Finalizes Initial Pandemic Order for 50 Million Injection Devices to Support Operation Warp Speed Vaccination Program 
From PR Newswire
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
New BD PurPrep™ skin preparation is the only commercially available PVP-I antiseptic skin preparation with sterile solution in the U.S. 
From PR Newswire
BD Launches Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes, Dramatically Expanding Access to COVID-19 Testing
- Simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings 
From PR Newswire
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2020 earnings conference call on Thursday, August 6, 2020, at 8:00 a.m.... 
From PR Newswire
Life-Saving Features Help Propel Wearable Technology to New Heights
FinancialBuzz.com News Commentary 
From PR Newswire
BD to Present at Investor Conferences
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor conferences: 
From PR Newswire
NYSE: BDX Investor Notice: Lawsuit against Becton, Dickinson and Company announced by Shareholders Foundation
From GlobeNewswire News Releases
BD to Present at Jefferies Virtual Healthcare Conference
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4,... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.